Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, Michael Ruberson Ribeiro da Silva, Ramon Gonçalves Pereira, Brian Godman, Marion Bennie, Hacene Nedjar & Elham Rahme. (2020) Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study. Current Medical Research and Opinion 36:4, pages 677-686.
Read now
Read now
Articles from other publishers (3)
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Blanca Garcia-Magallón, Ana Pérez-Gómez, Sara Manrique-Arija, Raquel Martín-Doménech, María Colazo, Cristina Campos, José Campos, Javier del Pino-Montes, Maria J. Arteaga, Luis Cea-Calvo, Federico Díaz-González & Juan J. Gómez-Reino. (2021) Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry. Clinical Rheumatology 40:10, pages 3979-3988.
Crossref
Crossref
Proton Rahman, Philip Baer, Ed Keystone, Denis Choquette, Carter Thorne, Boulos Haraoui, Andrew Chow, Rafat Faraawi, Wojciech Olszynski, John Kelsall, Emmanouil Rampakakis, Allen J. Lehman & Francois Nantel. (2020) Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry. BMC Rheumatology 4:1.
Crossref
Crossref
Chia-Ling Yu, Chung-Han Yang & Ching-Chi Chi. (2020) Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence. BioDrugs 34:5, pages 669-679.
Crossref
Crossref